NCT07160023 (CuTLy) is a clinical trial in Primary Cutaneous T-cell Lymphomas NCT Number, sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia.

Who is sponsoring NCT07160023?

NCT07160023 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia.

What condition does NCT07160023 study?

NCT07160023 studies Primary Cutaneous T-cell Lymphomas NCT Number.

Is NCT07160023 still recruiting?

NCT07160023 is currently recruiting now. Last updated 8 September 2025.

Last reviewed 2025-09-08 · How we verify

NCT07160023: CuTLy

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Local Registry of Primary Cutaneous T-cell Lymphomas

Recruiting now Last updated 8 September 2025

What this trial tests

trial in Primary Cutaneous T-cell Lymphomas NCT Number in 600 participants. Currently enrolling.

Timeline

12 October 2023

Primary endpoint
12 October 2033

12 October 2033

Quick facts

Lead sponsor	Fondazione IRCCS Policlinico San Matteo di Pavia
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	600
Start date	12 October 2023
Primary completion	12 October 2033
Estimated completion	12 October 2033
Sites	1 location across Italy

Conditions studied

Primary Cutaneous T-cell Lymphomas NCT Number — all drugs for Primary Cutaneous T-cell Lymphomas NCT Number →

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia

Who can join

6 and older, any sex, with Primary Cutaneous T-cell Lymphomas NCT Number. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This registry aims to collect retrospective and prospective data on patients with primary cutaneous T-cell lymphoma who are treated at the Dermatology Clinic of the IRCCS Policlinico San Matteo Foundation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Fondazione IRCCS Policlinico San Matteo di Pavia trials

Trials by the same sponsor.

NCT07534007 — Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zo · recruiting
NCT07494344 — Italian Retrospective/Prospective Observational Study on Prosthetic Surgery in Patients With Congenital Coagulation Dise · recruiting
NCT07356583 — Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on · recruiting
NCT07435207 — Thrombotic RIsk FActors in AL-goneurodystrophy · enrolling by invitation
NCT07263802 — Effect of a Food Supplement on Glycemic Parameters in Patients With Impaired Glucose Metabolism · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07160023 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione IRCCS Policlinico San Matteo di Pavia
Last refreshed: 8 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07160023.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing